University of Iowa, Holden Comprehensive Cancer Institute is a clinical research site located in Iowa City, Iowa, United States 52242.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
University of Iowa, Holden Comprehensive Cancer Institute has participated in 1 clinical trials.
Therapeutic areas: Cohort 1a and 1b: Glioma (Advanced Gliomas and Glioblastoma Multiforme), Cohort 2a and 2b: Hepatobiliary Tumors (Hepatocellular Carcinoma, Bile Duct Carcinoma, Intrahepatic Cholangiocarcinoma, Other Hepatobiliary Carcinomas), Cohort 3a and 3b: Chondrosarcoma.
Sponsors: Forma Therapeutics, Inc..
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Iowa, Holden Comprehensive Cancer Institute has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Iowa, Holden Comprehensive Cancer Institute has 1 clinical trials on record. Their work covers Cohort 1a and 1b: Glioma (Advanced Gliomas and Glioblastoma Multiforme), Cohort 2a and 2b: Hepatobiliary Tumors (Hepatocellular Carcinoma, Bile Duct Carcinoma, Intrahepatic Cholangiocarcinoma, Other Hepatobiliary Carcinomas), Cohort 3a and 3b: Chondrosarcoma.
University of Iowa, Holden Comprehensive Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.